Haemonetics (HAE) Misses Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.00 -0.16%
EPS Growth %: -0.9%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: -0.9%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.37, $0.09 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $243.2 million versus the consensus estimate of $245.08 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Xiaomi, Oppo, Vivo slash shipment targets up to 30% amid memory crunch - Nikkei
- Chip tool stocks surge up to 9% on Samsung, SK’s $1.3 trillion Korea bet
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
